Todd Sherer

Active 1999–2025

50
Papers
19,109
Citations
43
h-index
49
i10-index

Citations

Citations per year for Todd Sherer1986: 1 citations1996: 1 citations1999: 1 citations2000: 1 citations2001: 36 citations2002: 75 citations2003: 172 citations2004: 199 citations2005: 178 citations2006: 199 citations2007: 196 citations2008: 210 citations2009: 220 citations2010: 144 citations2011: 192 citations2012: 126 citations2013: 168 citations2014: 136 citations2015: 156 citations2016: 158 citations2017: 153 citations2018: 149 citations2019: 471 citations2020: 665 citations2021: 632 citations2022: 593 citations2023: 552 citations2024: 1,017 citations2025: 614 citations2026: 46 citations1987–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,467 citing papers, 26.5% of this breakdownChina: 772 citing papers, 8.3% of this breakdownUnited Kingdom: 722 citing papers, 7.8% of this breakdownGermany: 510 citing papers, 5.5% of this breakdownItaly: 465 citing papers, 5% of this breakdownCanada: 373 citing papers, 4% of this breakdownIndia: 288 citing papers, 3.1% of this breakdownSpain: 275 citing papers, 2.9% of this breakdownAustralia: 242 citing papers, 2.6% of this breakdownFrance: 232 citing papers, 2.5% of this breakdownNetherlands: 217 citing papers, 2.3% of this breakdownJapan: 204 citing papers, 2.2% of this breakdown
0%26.5%Other 27.3%

Fields

  • Medicine63%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Neuroscience10.7%
  • Computer Science2.9%
  • Agricultural and Biological Sciences1.8%
  • Engineering0.8%
  • Other4%

Topics

  • Parkinson's Disease Mechanisms and Treatments19.5%
  • Neurological disorders and treatments6.4%
  • Alzheimer's disease research and treatments3.8%
  • Nuclear Receptors and Signaling3.4%
  • Mitochondrial Function and Pathology2.8%
  • Nerve injury and regeneration2.4%
  • Other61.7%

Coauthors

All papers

Open in search
  1. The Emerging Evidence of the Parkinson Pandemic

    Authors: , , , - Journal of Parkinson s Disease 2018 cited by 1,963

  2. The Parkinson Progression Marker Initiative (PPMI)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 cited by 1,915

  3. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2023 cited by 693

  4. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Weintraub, Yuge Xiao, Andrew Siderowf, Billy Dunn, Kenneth Marek - The Lancet Neurology 2024 cited by 563

  5. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2018 cited by 686

  6. Chronic systemic pesticide exposure reproduces features of Parkinson's disease

    Authors: , , , , , - Nature Neuroscience 2000 cited by 3,682

  7. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

    Authors: , , , , , , , , , - Journal of Neuroscience 2003 cited by 1,079

  8. Six Action Steps to Address Global Disparities in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pramod Kumar Pal, Hiral Shah, Ali Shalash, Todd Sherer, Bernadette Siddiqui, Ted Thompson, Andreas Ullrich, Richard Walker, Tarun Dua - JAMA Neurology 2022 cited by 140

  9. Machine learning for comprehensive forecasting of Alzheimer’s Disease progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2019 cited by 217

  10. Proposal for a Biologic Staging System of Parkinson’s Disease

    Authors: , , , , , , - Journal of Parkinson s Disease 2023 cited by 85

  11. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2018 cited by 205

  12. LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongshi Yu, Xiang Wang, Todd Sherer - Science Translational Medicine 2020 cited by 130

  13. Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony A. Estrada, Ryan J. Watts - Science Translational Medicine 2015 cited by 370

  14. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2019 cited by 267

  15. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Seibyl, Susan Mendick, Norbert Schuff, Chelsea Caspell, Liz Uribe, Eric D. Foster, Katherine B. Gloer, Jon Yankey, Arthur W. Toga, Karen Crawford, Paola Casalin, Giulia Malferrari, Brit Mollenhauer, Douglas Galasko, Andrew Singleton, Keith A. Hawkins, David Russell, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Matthew Stern, Lana M. Chahine, James B. Leverenz, Samuel Frank, Irene Richard, Klaus Seppi, Holly A. Shill, Hubert Fernandez, Daniela Berg, Isabel Wurster, Douglas Galasko, Zoltan Mari, David J. Brooks, Nicola Pavese, Paolo Barone, Stuart Isaacson, Alberto J. Espay, Dominic B. Rowe, Melanie Brandabur, James W. Tetrud, Grace Liang, Álex Iranzo, Eduardo Tolosa, Laura Leary, C Riordan, Linda Rees, Alicia Portillo, Art Lenahan, Karen Williams, Stephanie Guthrie, Ashlee Brooke Rawlins, Sherry Harlan, Christine Hunter, Baochan Tran, Abigail Darin, Carly Linder, Marne Baca, Heli Venkov, Cathi-Ann Thomas, Raymond James, Cheryl Deeley, Courtney Bishop, Fabienne Sprenger, Diana Willeke, Sanja Obradov, Jennifer Mule, Nancy Monahan, Katharina Gauss and 98 more - Neurology 2017 cited by 152

  16. Long-Term Dementia Risk in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Siderowf, Douglas Galasko, Lana Chahine, Christopher S. Coffey, Kalpana Merchant, Kathleen L. Poston, Roseanne D. Dobkin, Tatiana Foroud, Brit Mollenhauer, Dan Weintraub, Ethan Brown, Karl Kieburtz, Duygu Tosun, Werner Poewe, Susan Bressman, Jan Hamer, Raymond James, Ekemini Riley, John Seibyl, Leslie M. Shaw, David G. Standaert, Sneha Mantri, Nabila Dahodwala, Michael A. Schwarzschild, Connie Marras, Hubert Fernandez, Ira Shoulson, Helen Rowbotham, Lucy Norcliffe‐Kaufmann, Paola Casalin, Claudia Trenkwalder, Todd Sherer, Sohini Chowdhury, Mark Frasier, Jamie L. Eberling, Katie Kopil, Alyssa O’Grady, James Gibaldi, Maggie Kuhl, L. Kirsch, Emily Flagg, Bridget McMahon, Craig Stanley, Kim Fabrizio, Dixie Ecklund, Trevis Huff, Richard M. Peters, Janel Fedler, Laura Heathers, Christopher Hobbick, Gena Antonopoulos, Chelsea Caspell‐Garcia, Michael C. Brumm, Arthur W. Toga, Karen Crawford, Andrew Singleton, Thomas J. Montine, Monica Korell, Ruth B. Schneider, Kelvin L. Chou, David Russell, Stewart A. Factor, Penelope Hogarth, Robert A. Hauser, Marie Saint‐Hilaire, David Shprecher, Kathrin Brockmann, Yen Tai, Paolo Barone, Stuart Isaacson and 82 more - Neurology 2024 cited by 74

  17. Finding useful biomarkers for Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Todd Sherer, Andrew Singleton, Margaret Sutherland, Ines Thiele, Marcel van der Brug, Kendall Van Keuren‐Jensen, David E. Vaillancourt, David R. Walt, Andrew B. West, Jing Zhang - Science Translational Medicine 2018 cited by 151

  18. Disease modification and biomarker development in Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2020 cited by 134

  19. LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

    Authors: , , , , , , , , , , , , , , , , , , , , - npj Parkinson s Disease 2023 cited by 41

  20. Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system

    Authors: , , , , , , , , , , , , , , , , - Neurobiology of Disease 2006 cited by 343

  21. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neurobiology of Disease 2014 cited by 227

  22. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nichole Daegele, Cynthia Casaceli, Ray Dorsey, Renée Wilson, Sugi Mahes, Christina M. Salerno, Karen Crawford, Paola Casalin, Giulia Malferrari, Mali Gani Weisz, Avi Orr‐Urtreger, Thomas J. Montine, Chris Baglieri, Amanda Christini, David Russell, Nabila Dahodwala, Nir Giladi, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Marie Saint‐Hilaire, Irene Hegeman Richard, David Shprecher, Hubert Fernandez, Katrina Brockmann, Liana S. Rosenthal, Paolo Barone, Alberto J. Espay, Dominic B. Rowe, Karen Marder, A. Parra Santiago, Shu‐Ching Hu, Stuart Isaacson, Jean‐Christophe Corvol, Javiar Ruiz Martinez, Eduardo Tolosa, Yen Tai, Marios Politis, Debra Smejdir, Linda Rees, Karen Williams, Farah Kausar, Karen Williams, Whitney Richardson, Diana Willeke, Shawnees Peacock, Barbara Sommerfeld, Alison Freed, Katrina Wakeman, Courtney Blair, Stephanie Guthrie, Leigh Harrell, Christine Hunter, Cathi-Ann Thomas, Raymond James, Grace A. Zimmerman, Victoria Brown, Jennifer Mule, Ella Hilt, Kori Ribb, Susan Ainscough, Misty Wethington, Madelaine Ranola, Helen Mejia Santana, Juliana Moreno, Deborah Raymond, Krista Speketer, Lisbeth Carvajal and 34 more - The Lancet Neurology 2019 cited by 139

  23. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease

    Authors: , , , , , , , , - Journal of Neurochemistry 2006 cited by 347

  24. Animal models of Parkinson's disease

    Authors: , , - BioEssays 2002 cited by 592